ACON logo

ACLARION INC

ACONNASDAQ
🏆 #5387 by market capEarnings Nov 11US Equity
$71.87▲ $6.31 (+8.78%)
Simulated price
🔔
Track ACON
Get earnings, price moves & breaking news on Telegram
Track
24h▲ 8.8%
7d—
14d—
30d—
ytd—
1y—
🏦Market Cap
$1M
Small Cap
📈Revenue Growth (YoY)
+65.6%
High Growth
📊Gross Margin
-51.0%
Thin
💵FCF Margin
-9652.9%
Thin
⚖️P/S Ratio
16.5x
Expensive
Otter Score
28
Weak
No chart data available for ACON.

Trading Snapshot

Day Range
$70.89 – $73.07
52-Week Range
$1.95 – $12.03
Volume
$3.35B
Avg Volume
$2.41B
Shares Outstanding
533,308
Next Earnings
Dec 15, 2026

Fundamentals Snapshot

Annual Revenue
$75,730
Last Q Revenue
$25,208
P/E Ratio
-0.3
P/S Ratio
16.5x
EPS (TTM)
$-3.74
Dividend Yield
0.00%
Dilution (1yr)
+41400.5%

Why Investors Own ACON

  • ✓High-growth profile — revenue up -2.0% YoY with expanding US Equity exposure.
  • ✓Healthy economics — 30% gross margin and 23% free-cash-flow margin.
  • ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

ACON logo

ACLARION INC

ACON
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$76K▲ +65.6% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
-291.3%▲ +58.5% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
−$7M▲ +27.9% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
−$7M▲ +28.5% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
532K▲ +41400.5% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$12M▲ +$12M YoY
StockOtter · stockotter.space

About ACLARION INC

Aclarion, Inc., a healthcare technology enterprise based in San Mateo, California, was founded in 2008 and operates within the United States. The company specializes in creating software for magnetic resonance spectroscopy (MRS) applications. Its primary product is the NOCISCAN-LS Post-Processor suite, which features two key components: NOCICALC-LS, designed to analyze MRS data from discs to quantify degenerative pain biomarkers, and NOCIGRAM-LS, a software tool that assists in clinical decision-making. The company adopted its current name, Aclarion, Inc., in December 2021, having previously been known as Nocimed, Inc.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)
💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
💧Dilution★★★★★
Overall Score
Weak
28/100

Analyst Price Target

ⓘ
Average Target
$69.22
▼ −3.7% Downside
High Target$76.41
Low Target$58.43
Based on 15 analysts

Latest News & Updates

🚀
Barron’s·2h ago

ACLARION INC tops quarterly estimates as demand accelerates

Revenue grew double digits with management guiding above consensus; margins continued to expand.

🛰️
Reuters·5h ago

Analysts lift ACON price targets on improving margins

Several firms raised targets, citing stronger free cash flow and a healthier backlog.

🌌
MarketWatch·1d ago

ACLARION INC announces new agreement to expand its footprint

The move broadens the company’s reach and could add incremental revenue over the next year.